View expert analysis as to whether the stock is a strong buy, strong sell or hold, based on analyst 12-Month FME share price predictions and stock forecast targets. An estimate of a stock's true price ...

Diversified by geography and business mix, Fresenius should be able to benefit from ongoing growth in treating ESRD patients worldwide in the long run.